MoonLake Immunotherapeutics (MLTX) is down -89.1%, or -$55.25 to $6.74.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLTX:
- Why Is MoonLake Immunotherapeutics Stock (MLTX) Down 90% Today?
- Video: Merus jumps after deal to be bought, MoonLake sinks after trial data
- Morning Movers: Tilray rises as Trump touts CBD benefits for seniors
- MoonLake Immunotherapeutics: Hold Rating Due to Unfavorable Phase 3 Results and Uncertain Market Prospects
- MoonLake Immunotherapeutics down 88% at $7.67 after Phase 3 HS data